Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis - 59(2020), 6 vom: 24. Dez., Seite 102904 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tatar, Erhan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amides |
|---|
| Anmerkungen: |
Date Completed 23.12.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.transci.2020.102904 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313822131 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313822131 | ||
| 003 | DE-627 | ||
| 005 | 20231225151413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.transci.2020.102904 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM313822131 | ||
| 035 | |a (NLM)32807652 | ||
| 035 | |a (PII)S1473-0502(20)30218-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tatar, Erhan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.12.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Amides |2 NLM | |
| 650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
| 650 | 7 | |a Pyrazines |2 NLM | |
| 650 | 7 | |a favipiravir |2 NLM | |
| 650 | 7 | |a EW5GL2X7E0 |2 NLM | |
| 700 | 1 | |a Karatas, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Bozaci, Ilter |e verfasserin |4 aut | |
| 700 | 1 | |a Ari, Alpay |e verfasserin |4 aut | |
| 700 | 1 | |a Acar, Turker |e verfasserin |4 aut | |
| 700 | 1 | |a Simsek, Cenk |e verfasserin |4 aut | |
| 700 | 1 | |a Yildirim, Ali Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Yildirim, Ozden |e verfasserin |4 aut | |
| 700 | 1 | |a Uslu, Adam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis |d 2001 |g 59(2020), 6 vom: 24. Dez., Seite 102904 |w (DE-627)NLM114008043 |x 1473-0502 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2020 |g number:6 |g day:24 |g month:12 |g pages:102904 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.transci.2020.102904 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2020 |e 6 |b 24 |c 12 |h 102904 | ||